Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8501731
APP PUB NO 20110112061A1
SERIAL NO

12933104

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a class of pyridazinones of formula I, which comprises 6-[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one as a mother nucleus, the preparation method thereof and the use thereof in manufacturing medicaments against tumors, especially liver cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chao, Bo Shanghai, CN 5 24
Hu, Youhong Shanghai, CN 12 71
Lin, Shijun Shanghai, CN 2 21
Liu, Zhende Shanghai, CN 7 23
Lou, Liguang Shanghai, CN 3 22
Xu, Yongping Shanghai, CN 3 21
Zhao, Hongbing Shanghai, CN 3 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 6, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00